sr 48692 has been researched along with bisbenzimidazole in 1 studies
Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (bisbenzimidazole) | Trials (bisbenzimidazole) | Recent Studies (post-2010) (bisbenzimidazole) |
---|---|---|---|---|---|
203 | 3 | 36 | 1,218 | 2 | 170 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonelli, T; De Mattei, M; Ferraro, L; Finetti, S; Fournier, J; Fuxe, K; Tanganelli, S; Tomasini, MC | 1 |
1 other study(ies) available for sr 48692 and bisbenzimidazole
Article | Year |
---|---|
Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity.
Topics: Animals; Bisbenzimidazole; Calcium; Cells, Cultured; Cerebral Cortex; Chromatin; Coloring Agents; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Extracellular Space; Glutamic Acid; N-Methylaspartate; Naphthalenes; Neurons; Neurotensin; Neurotoxicity Syndromes; Peptide Fragments; Pyrazoles; Quinolines; Rats; Receptors, Neurotensin | 2004 |